CONDITIONS TREATED 

PROCEDURES 

Steven Copenhaver, MD

Pulmonologist Pediatric Pulmonary & Sleep Specialists
972.566.6996 7777 Forest Lane
Suite B-309
Dallas, TX 75230
5+ Years of Medical Experience

Biography

Dr. Steven Copenhaver is double boarded by both the American Board of Pediatrics and Pediatric Pulmonary Medicine. Dr. Copenhaver’s areas of interests include cystic fibrosis, asthma, bronchopulmonary dysplasia/chronic lung diseases, chronic mechanical ventilation and airway abnomalities, and flexible bronchoscopy.

Conditions Dr. Steven Copenhaver treats include:

  • Acute and Chronic Upper Airway Constriction
  • Acute Pneumonia
  • Acute Respiratory Distress
  • Apnea of Prematurity and Infancy
  • Asthma
  • Bronchitis
  • Bronchopulmonary Dysplasia
  • Chronic Lung Disease
  • Chronic Respiratory Insufficiency
  • Complicated Pneumonia with Pleural Effusion
  • Congenital Lung Anomalies
  • Cystic Fibrosis
  • Disphagia/Discoordinated swallowing, aspiration, cerebral palsy
  • Evaluation of Recurrent infections, including bronchitis and pneumonia
  • Gastroesophageal (GERD)/Infant Reflux
  • Neurologic disorders, SMA
  • Neuromuscular weakness, muscular dystrophy
  • Pulmonary Complications of Prematurity

Dr. Copenhaver and the staff at Pediatric Pulmonary & Sleep Specialists provide Synagis injections for premature and low birth weight infants to help prevent RSV infection. Synagis is also recommended for infants less than 2 years of age with hemodynamically significant cyanotic and acyanotic congenital heart disease and chronic lung disease. The shot is given monthly, and the first dose is usually given before the season begins. In the Southern region, the season runs from approximately October to March.

Respiratory Syncytial Virus (RSV) is a virus which is easily spread. Almost all children are exposed to RSV by the time they turn 2 years old. For premature babies and babies with significant heart disease, RSV can be very serious.

Synagis is also recommended for infants less than 2 years of age with hemodynamically significant cyanotic and acyanotic congenital heart disease and chronic lung disease. The shot is given monthly, and the first dose is usually given before the season begins. In the Southern region, the season runs from approximately October to March.

Dr. Copenhaver’s Synagis staff handles the prior authorization, letters of medical necessity and insurance verification on Synagis patients who are referred to our office. Providers can fax the Synagis Enrollment Form to 972-384-4486 to start the process. We will contact the patients for an appointment once we receive authorization from the insurance company.

Dr. Copenhaver is a clinical faculty member at University of Texas Southwestern Medical School. He is part of the Cystic Fibrosis team at Children’s Medical Center of Dallas. He is also part of the in-patient ventilation unit and out-patient ventilation clinics at Our Children’s House at Baylor. Dr. Copenhaver enjoys medical privileges at most Northern and Central Dallas Medical Centers.

 

  • Date Format: MM slash DD slash YYYY

Dial 9-1-1 if this is a medical emergency

 
DallasFort Worth